In Search of New Targets and Endpoints in Heart Failure With Preserved Ejection Fraction

JACC: Heart Failure

Volumn 3, Issue 6, 2015, Pages 475-477

  Borlaug, Barry A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diastole; Exercise; Heart failure; Outcomes; Pulmonary hypertension

Indexed keywords

DAILY LIFE ACTIVITY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSPNEA; EDITORIAL; EXERCISE TOLERANCE; FATIGUE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE COMPLIANCE; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RISK ASSESSMENT; TREATMENT INDICATION; WALKING; EXERCISE TEST; FEMALE; HEART FAILURE; HEART STROKE VOLUME; LUNG WEDGE PRESSURE; MALE; PHYSIOLOGY;

EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; PULMONARY WEDGE PRESSURE; STROKE VOLUME;

EID: 84930862139     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.02.007     Document Type: Editorial

References (15)

1. Borlaug B.A., Paulus W.J. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011, 32:670-679.
2. Lam C.S., Roger V.L., Rodeheffer R.J., Borlaug B.A., Enders F.T., Redfield M.M. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. JAm Coll Cardiol 2009, 53:1119-1126.
3. Melenovsky V., Hwang S.J., Lin G., Redfield M.M., Borlaug B.A. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014, 35:3452-3462.
4. Mohammed S.F., Hussain I., Abou Ezzeddine O.F., et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 2014, 130:2310-2320.
5. Al-Naamani N., Preston I.R., Paulus J.K., Hill N.S., Roberts K.E. Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction. JAm Coll Cardiol HF 2015, 3:467-474.
6. Vachiery J.L., Adir Y., Barbera J.A., et al. Pulmonary hypertension due to left heart diseases. JAm Coll Cardiol 2013, 62:D100-D108.
7. Tedford R.J., Hassoun P.M., Mathai S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012, 125:289-297.
8. Miller W.L., Grille D.E., Borlaug B.A. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction. JAm Coll Cardiol HF 2013, 1:290-299.
9. Dupont M., Mullens W., Skouri H.N., et al. Prognostic role of pulmonary arterial capacitance in advanced heart failure. Circ Heart Fail 2012, 5:778-785.
10. Tampakakis E., Leary P.J., Selby V.N., et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JAm Coll Cardiol HF 2015, 3:9-16.
11. Chatterjee N.A., Lewis G.D. Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: limitations of a solitary measurement. JAm Coll Cardiol HF 2015, 3:17-21.
12. Zotter-Tufaro C., Mascherbauer J., Duca F., et al. Prognostic significance and determinants of the 6-min walk test in patients with heart failure and preserved ejection fraction. JAm Coll Cardiol HF 2015, 3:459-466.
13. Mangla A., Kane J., Beaty E., Richardson D., Powell L.H., Calvin J.E. Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol 2013, 112:1907-1912.
14. Abudiab M.M., Redfield M.M., Melenovsky V., et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 2013, 15:776-785.
15. Mohammed S.F., Hussain S., Mirzoyev S.A., Edwards W.D., Maleszewski J.J., Redfield M.M. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 2015, 131:550-559.